Calquence and Swelling - a phase IV clinical study of FDA data

Summary:

Swelling is reported as a side effect among people who take Calquence (acalabrutinib), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Jakafi, and have Chronic lymphocytic leukaemia.

The phase IV clinical study analyzes which people have Swelling when taking Calquence. It is created by eHealthMe based on reports of 5,620 people who have side effects when taking Calquence from the FDA, and is updated regularly.

What is Calquence?

Calquence has active ingredients of acalabrutinib. eHealthMe is studying from 5,627 Calquence users. Check the latest studies of Calquence.

What is Swelling?

Swelling is found to be associated with 2,295 drugs and 2,899 conditions by eHealthMe. Check the latest studies of Swelling.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

5,620 people reported to have side effects when taking Calquence.
Among them, 24 people (0.43%) have Swelling.

Among these 24 people:

How long have people been on Calquence when they have Swelling? *

What is the gender of people who have Swelling when taking Calquence? *

female: 35.71 %
male: 64.29 %

What is the age of people who have Swelling when taking Calquence? *

What are other drugs people take besides Calquence? *

What are other side effects people have besides Swelling? *

Itching: 7 people, 29.17%
Fatigue (feeling of tiredness): 7 people, 29.17%
Dizziness: 6 people, 25.00%
Memory Loss: 5 people, 20.83%
Head Injury: 5 people, 20.83%
Pain: 5 people, 20.83%
Blood Creatinine Abnormal: 4 people, 16.67%
Joint Instability (a condition in which the joints aren't sufficiently supported): 4 people, 16.67%
Fall: 4 people, 16.67%
Constipation: 4 people, 16.67%

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 11 people, 45.83%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 16.67%
Neoplasm Malignant (cancer tumour): 2 people, 8.33%
Bladder Cancer: 2 people, 8.33%
B-Cell Small Lymphocytic Lymphoma (blood cancer affecting b cells): 2 people, 8.33%
Prostate Cancer: 1 person, 4.17%
Leukaemia (blood or bone marrow cancer): 1 person, 4.17%
High Blood Cholesterol: 1 person, 4.17%
Heart Disease: 1 person, 4.17%
Cardiac Disorder: 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Calquence and have Swelling?

- Check whether Swelling is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Calquence:

Calquence (5,627 reports)

Swelling treatments and more:

Swelling (115,742 reports)

Browse all side effects of Calquence:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling:

Swelling (2,295 drugs)

Browse all the conditions that are associated with Swelling:

Swelling (2,899 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acalabrutinib (the active ingredients of Calquence) and Calquence (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.